Form 4: Insmed Inc. Chief Legal Officer Michael Smith Reports Stock Sales and Option Exercises
SEC Form 4 Filing
Michael Smith, Chief Legal Officer of Insmed Inc., reports the exercise of stock options and subsequent sale of shares on August 12, 2024.
Summary
- On August 12, 2024, Michael Smith, the Chief Legal Officer of Insmed Inc., exercised stock options to acquire a total of 88,070 shares of common stock.
- These options were exercised at prices of $17.16, $13.91, and $17.07 per share.
- Following the exercise of these options, Smith sold 67,655 shares at a weighted average price of $72.75 and 20,415 shares at a weighted average price of $73.65.
- After these transactions, Smith directly owns 88,727 shares of Insmed Inc. common stock and options to purchase 34,530 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. The sentiment is neither positive nor negative as it simply reflects the insider's trading activity.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, providing transparency to the market regarding their investment activities in the company.
Stakeholder Impact
- The stock sales may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of stock option exercise and stock sales. |
| 08/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.